APO RESEARCH · REPORT
10-Deacetylbaccatin III
10-Deacetylbaccatin III is a taxane-scaffold chemical supplied as an identified research or manufacturing input.

Product & engineering
Understand the product.
This report studies the 10-Deacetylbaccatin III market. 10-Deacetylbaccatin III, also known as 10-DAB or 10-DAB III, is a closely related natural organic compounds isolated from dried needles and small branches of the European yew tree (Taxus baccata).10-Deacetylbaccatin III is a precursor to the anti-cancer drug docetaxel (Taxotere). pacitaxel (taxol); cabazitaxel. 10-10-deacetylbaccatin III was found to selectively inhibit the growth of L. DONOVANI intracellular amastigotes within J774 murine macrophages in vitro at nanomolar concentrations with an IC(50) value of 70 nM.
Chemical identity, substitution pattern, assay and related impurities define the supplied material. The named chemical category does not establish a finished formulation’s compatibility, end-use approval or performance; those depend on the actual grade and application.
The commercial boundary
Use the selected edition’s stated product level, geography, years and measurement basis. Materials, components, finished systems and services are separate commercial boundaries unless that edition explicitly combines them.
Which supplied interfaces and acceptance criteria define 10-Deacetylbaccatin III?
Chemical identity, substitution pattern, assay and related impurities define the supplied material. The named chemical category does not establish a finished formulation’s compatibility, end-use approval or performance; those depend on the actual grade and application.
Technical reading
Selected research
Industry Growth & Trends
Global 10-Deacetylbaccatin III Industry Growth and Trends Forecast to 2032
Market perspective
This report studies the 10-Deacetylbaccatin III market. 10-Deacetylbaccatin III, also known as 10-DAB or 10-DAB III, is a closely related natural organic compounds isolated from dried needles and small branches of the European yew tree (Taxus baccata).10-Deacetylbaccatin III is a precursor to the anti-cancer drug docetaxel (Taxotere). pacitaxel (taxol); cabazitaxel. 10-10-deacetylbaccatin III was found to selectively inhibit the growth of L. DONOVANI intracellular amastigotes within J774 murine macrophages in vitro at nanomolar concentrations with an IC(50) value of 70 nM.
Global 10-Deacetylbaccatin III key players include SM Herbals, Alchem International, Indena, etc. Global top three manufacturers hold a share over 50%.
China is the largest market, with a share over 35%, followed by United States and Europe, both have a share over 50 percent.
Read the full market overview
In terms of product, ≥98.0% is the largest segment, with a share over 85%. And in terms of application, the largest application is Production of Docetaxel, followed by Production of Paclitaxel, etc.
Report Scope
This report provides a structured, data-driven view of the global 10-Deacetylbaccatin III market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.
The 10-Deacetylbaccatin III market size, estimates, and forecasts are presented in terms of sales volume (kg) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global 10-Deacetylbaccatin III market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to 10-Deacetylbaccatin III.
Key Companies & Market Share Insights
This section analyzes the strategies and performance of leading manufacturers in the global 10-Deacetylbaccatin III market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.
10-Deacetylbaccatin III Market by Company
SM Herbals
Alchem International
Indena
South Pharmaceutical
HAOXUAN
Yuannan Hande
Sai Phytoceuticals
Sarv Biolabs Pvt
Aphios
Hainan Yew Pharmaceutical
10-Deacetylbaccatin III Segment by Type
Above 95%
Above 98.0%
Others
10-Deacetylbaccatin III Segment by Application
Production of Docetaxel
Production of Paclitaxel
Others
10-Deacetylbaccatin III Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global 10-Deacetylbaccatin III market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of 10-Deacetylbaccatin III and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of 10-Deacetylbaccatin III.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of 10-Deacetylbaccatin III manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Sales, revenue of 10-Deacetylbaccatin III in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.
Chapter 13: Concluding Insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Above 95%
- Above 98.0%
- Others
Applications
- Production of Docetaxel
- Production of Paclitaxel
- Others
Companies covered
- SM Herbals
- Alchem International
- Indena
- South Pharmaceutical
- HAOXUAN
- Yuannan Hande
- Sai Phytoceuticals
- Sarv Biolabs Pvt
- Aphios
- Hainan Yew Pharmaceutical
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.2.1 Global 10-Deacetylbaccatin III Market Size Estimates and Forecasts (2021-2032)
- 1.2.2 Global 10-Deacetylbaccatin III Sales Estimates and Forecasts (2021-2032)
- 1.3 10-Deacetylbaccatin III Market by Type
- 1.3.1 Above 95%
- 1.3.2 Above 98.0%
- 1.3.3 Others
- 1.4 Global 10-Deacetylbaccatin III Market Size by Type
- 1.4.1 Global 10-Deacetylbaccatin III Market Size Overview by Type (2021-2032)
- 1.4.2 Global 10-Deacetylbaccatin III Historic Market Size Review by Type (2021-2026)
- 1.4.3 Global 10-Deacetylbaccatin III Forecasted Market Size by Type (2027-2032)
- 1.5 Key Regions Market Size by Type
- 1.5.1 North America 10-Deacetylbaccatin III Sales Breakdown by Type (2021-2026)
- 1.5.2 Europe 10-Deacetylbaccatin III Sales Breakdown by Type (2021-2026)
- 1.5.3 Asia-Pacific 10-Deacetylbaccatin III Sales Breakdown by Type (2021-2026)
- 1.5.4 South America 10-Deacetylbaccatin III Sales Breakdown by Type (2021-2026)
- 1.5.5 Middle East and Africa 10-Deacetylbaccatin III Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
- 2.1 10-Deacetylbaccatin III Industry Trends
- 2.2 10-Deacetylbaccatin III Industry Drivers
- 2.3 10-Deacetylbaccatin III Industry Opportunities and Challenges
- 2.4 10-Deacetylbaccatin III Industry Restraints
3 Market Competitive Landscape by Company
- 3.1 Global Top Players by 10-Deacetylbaccatin III Revenue (2021-2026)
- 3.2 Global Top Players by 10-Deacetylbaccatin III Sales (2021-2026)
- 3.3 Global Top Players by 10-Deacetylbaccatin III Price (2021-2026)
- 3.4 Global 10-Deacetylbaccatin III Industry Company Ranking, 2024 VS 2025 VS 2026
- 3.5 Global 10-Deacetylbaccatin III Major Company Production Sites & Headquarters
- 3.6 Global 10-Deacetylbaccatin III Company, Product Type & Application
- 3.7 Global 10-Deacetylbaccatin III Company Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global 10-Deacetylbaccatin III Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 10-Deacetylbaccatin III Players Market Share by Revenue in 2025
- 3.8.3 2025 10-Deacetylbaccatin III Tier 1, Tier 2, and Tier 3
4 10-Deacetylbaccatin III Regional Status and Outlook
- 4.1 Global 10-Deacetylbaccatin III Market Size and CAGR by Region: 2021 VS 2025 VS 2032
- 4.2 Global 10-Deacetylbaccatin III Historic Market Size by Region
- 4.2.1 Global 10-Deacetylbaccatin III Sales in Volume by Region (2021-2026)
- 4.2.2 Global 10-Deacetylbaccatin III Sales in Value by Region (2021-2026)
- 4.2.3 Global 10-Deacetylbaccatin III Sales (Volume & Value), Price and Gross Margin (2021-2026)
- 4.3 Global 10-Deacetylbaccatin III Forecasted Market Size by Region
- 4.3.1 Global 10-Deacetylbaccatin III Sales in Volume by Region (2027-2032)
- 4.3.2 Global 10-Deacetylbaccatin III Sales in Value by Region (2027-2032)
- 4.3.3 Global 10-Deacetylbaccatin III Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 10-Deacetylbaccatin III by Application
- 5.1 10-Deacetylbaccatin III Market by Application
- 5.1.1 Production of Docetaxel
- 5.1.2 Production of Paclitaxel
- 5.1.3 Others
- 5.2 Global 10-Deacetylbaccatin III Market Size by Application
- 5.2.1 Global 10-Deacetylbaccatin III Market Size Overview by Application (2021-2032)
- 5.2.2 Global 10-Deacetylbaccatin III Historic Market Size Review by Application (2021-2026)
- 5.2.3 Global 10-Deacetylbaccatin III Forecasted Market Size by Application (2027-2032)
- 5.3 Key Regions Market Size by Application
- 5.3.1 North America 10-Deacetylbaccatin III Sales Breakdown by Application (2021-2026)
- 5.3.2 Europe 10-Deacetylbaccatin III Sales Breakdown by Application (2021-2026)
- 5.3.3 Asia-Pacific 10-Deacetylbaccatin III Sales Breakdown by Application (2021-2026)
- 5.3.4 South America 10-Deacetylbaccatin III Sales Breakdown by Application (2021-2026)
- 5.3.5 Middle East and Africa 10-Deacetylbaccatin III Sales Breakdown by Application (2021-2026)
6 Company Profiles
- 6.1 SM Herbals
- 6.1.1 SM Herbals Company Information
- 6.1.2 SM Herbals Business Overview
- 6.1.3 SM Herbals 10-Deacetylbaccatin III Sales, Revenue and Gross Margin (2021-2026)
- 6.1.4 SM Herbals 10-Deacetylbaccatin III Product Portfolio
- 6.1.5 SM Herbals Recent Developments
- 6.2 Alchem International
- 6.2.1 Alchem International Company Information
- 6.2.2 Alchem International Business Overview
- 6.2.3 Alchem International 10-Deacetylbaccatin III Sales, Revenue and Gross Margin (2021-2026)
- 6.2.4 Alchem International 10-Deacetylbaccatin III Product Portfolio
- 6.2.5 Alchem International Recent Developments
- 6.3 Indena
- 6.3.1 Indena Company Information
- 6.3.2 Indena Business Overview
- 6.3.3 Indena 10-Deacetylbaccatin III Sales, Revenue and Gross Margin (2021-2026)
- 6.3.4 Indena 10-Deacetylbaccatin III Product Portfolio
- 6.3.5 Indena Recent Developments
- 6.4 South Pharmaceutical
- 6.4.1 South Pharmaceutical Company Information
- 6.4.2 South Pharmaceutical Business Overview
- 6.4.3 South Pharmaceutical 10-Deacetylbaccatin III Sales, Revenue and Gross Margin (2021-2026)
- 6.4.4 South Pharmaceutical 10-Deacetylbaccatin III Product Portfolio
- 6.4.5 South Pharmaceutical Recent Developments
- 6.5 HAOXUAN
- 6.5.1 HAOXUAN Company Information
- 6.5.2 HAOXUAN Business Overview
- 6.5.3 HAOXUAN 10-Deacetylbaccatin III Sales, Revenue and Gross Margin (2021-2026)
- 6.5.4 HAOXUAN 10-Deacetylbaccatin III Product Portfolio
- 6.5.5 HAOXUAN Recent Developments
- 6.6 Yuannan Hande
- 6.6.1 Yuannan Hande Company Information
- 6.6.2 Yuannan Hande Business Overview
- 6.6.3 Yuannan Hande 10-Deacetylbaccatin III Sales, Revenue and Gross Margin (2021-2026)
- 6.6.4 Yuannan Hande 10-Deacetylbaccatin III Product Portfolio
- 6.6.5 Yuannan Hande Recent Developments
- 6.7 Sai Phytoceuticals
- 6.7.1 Sai Phytoceuticals Company Information
- 6.7.2 Sai Phytoceuticals Business Overview
- 6.7.3 Sai Phytoceuticals 10-Deacetylbaccatin III Sales, Revenue and Gross Margin (2021-2026)
- 6.7.4 Sai Phytoceuticals 10-Deacetylbaccatin III Product Portfolio
- 6.7.5 Sai Phytoceuticals Recent Developments
- 6.8 Sarv Biolabs Pvt
- 6.8.1 Sarv Biolabs Pvt Company Information
- 6.8.2 Sarv Biolabs Pvt Business Overview
- 6.8.3 Sarv Biolabs Pvt 10-Deacetylbaccatin III Sales, Revenue and Gross Margin (2021-2026)
- 6.8.4 Sarv Biolabs Pvt 10-Deacetylbaccatin III Product Portfolio
- 6.8.5 Sarv Biolabs Pvt Recent Developments
- 6.9 Aphios
- 6.9.1 Aphios Company Information
- 6.9.2 Aphios Business Overview
- 6.9.3 Aphios 10-Deacetylbaccatin III Sales, Revenue and Gross Margin (2021-2026)
- 6.9.4 Aphios 10-Deacetylbaccatin III Product Portfolio
- 6.9.5 Aphios Recent Developments
- 6.10 Hainan Yew Pharmaceutical
- 6.10.1 Hainan Yew Pharmaceutical Company Information
- 6.10.2 Hainan Yew Pharmaceutical Business Overview
- 6.10.3 Hainan Yew Pharmaceutical 10-Deacetylbaccatin III Sales, Revenue and Gross Margin (2021-2026)
- 6.10.4 Hainan Yew Pharmaceutical 10-Deacetylbaccatin III Product Portfolio
- 6.10.5 Hainan Yew Pharmaceutical Recent Developments
7 North America by Country
- 7.1 North America 10-Deacetylbaccatin III Sales by Country
- 7.1.1 North America 10-Deacetylbaccatin III Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.1.2 North America 10-Deacetylbaccatin III Sales by Country (2021-2026)
- 7.1.3 North America 10-Deacetylbaccatin III Sales Forecast by Country (2027-2032)
- 7.2 North America 10-Deacetylbaccatin III Market Size by Country
- 7.2.1 North America 10-Deacetylbaccatin III Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.2.2 North America 10-Deacetylbaccatin III Market Size by Country (2021-2026)
- 7.2.3 North America 10-Deacetylbaccatin III Market Size Forecast by Country (2027-2032)
8 Europe by Country
- 8.1 Europe 10-Deacetylbaccatin III Sales by Country
- 8.1.1 Europe 10-Deacetylbaccatin III Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.1.2 Europe 10-Deacetylbaccatin III Sales by Country (2021-2026)
- 8.1.3 Europe 10-Deacetylbaccatin III Sales Forecast by Country (2027-2032)
- 8.2 Europe 10-Deacetylbaccatin III Market Size by Country
- 8.2.1 Europe 10-Deacetylbaccatin III Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.2.2 Europe 10-Deacetylbaccatin III Market Size by Country (2021-2026)
- 8.2.3 Europe 10-Deacetylbaccatin III Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
- 9.1 Asia-Pacific 10-Deacetylbaccatin III Sales by Country
- 9.1.1 Asia-Pacific 10-Deacetylbaccatin III Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.1.2 Asia-Pacific 10-Deacetylbaccatin III Sales by Country (2021-2026)
- 9.1.3 Asia-Pacific 10-Deacetylbaccatin III Sales Forecast by Country (2027-2032)
- 9.2 Asia-Pacific 10-Deacetylbaccatin III Market Size by Country
- 9.2.1 Asia-Pacific 10-Deacetylbaccatin III Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.2.2 Asia-Pacific 10-Deacetylbaccatin III Market Size by Country (2021-2026)
- 9.2.3 Asia-Pacific 10-Deacetylbaccatin III Market Size Forecast by Country (2027-2032)
10 South America by Country
- 10.1 South America 10-Deacetylbaccatin III Sales by Country
- 10.1.1 South America 10-Deacetylbaccatin III Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.1.2 South America 10-Deacetylbaccatin III Sales by Country (2021-2026)
- 10.1.3 South America 10-Deacetylbaccatin III Sales Forecast by Country (2027-2032)
- 10.2 South America 10-Deacetylbaccatin III Market Size by Country
- 10.2.1 South America 10-Deacetylbaccatin III Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.2.2 South America 10-Deacetylbaccatin III Market Size by Country (2021-2026)
- 10.2.3 South America 10-Deacetylbaccatin III Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
- 11.1 Middle East and Africa 10-Deacetylbaccatin III Sales by Country
- 11.1.1 Middle East and Africa 10-Deacetylbaccatin III Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.1.2 Middle East and Africa 10-Deacetylbaccatin III Sales by Country (2021-2026)
- 11.1.3 Middle East and Africa 10-Deacetylbaccatin III Sales Forecast by Country (2027-2032)
- 11.2 Middle East and Africa 10-Deacetylbaccatin III Market Size by Country
- 11.2.1 Middle East and Africa 10-Deacetylbaccatin III Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.2.2 Middle East and Africa 10-Deacetylbaccatin III Market Size by Country (2021-2026)
- 11.2.3 Middle East and Africa 10-Deacetylbaccatin III Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
- 12.1 10-Deacetylbaccatin III Value Chain Analysis
- 12.1.1 10-Deacetylbaccatin III Key Raw Materials
- 12.1.2 Key Raw Materials Price
- 12.1.3 Raw Materials Key Suppliers
- 12.1.4 Manufacturing Cost Structure
- 12.1.5 10-Deacetylbaccatin III Production Mode & Process
- 12.2 10-Deacetylbaccatin III Sales Channels Analysis
- 12.2.1 Direct Comparison with Distribution Share
- 12.2.2 10-Deacetylbaccatin III Distributors
- 12.2.3 10-Deacetylbaccatin III Customers
13 Concluding Insights
14 Appendix
- 14.1 Reasons for Doing This Study
- 14.2 Research Methodology
- 14.3 Research Process
- 14.4 Authors List of This Report
- 14.5 Data Source
- 14.5.1 Secondary Sources
- 14.5.2 Primary Sources
- 14.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst